Ex-PDL Exec Can't Dodge MedImmune Subpoena

Law360, New York (July 1, 2010, 7:01 PM EDT) -- An ex-PDL BioPharma Inc. executive will have to testify in a patent suit MedImmune LLC brought against PDL over MedImmune's respiratory drugs Synagis and the yet-to-be released motavizumab, having failed to convince a judge that coming to the U.S. to be deposed would be unduly burdensome for him.

Magistrate Judge Howard Lloyd of the U.S. District Court for the Northern District of California signed off on an order Wednesday denying ex-PDL CEO Mark McDade's motion to quash a subpoena.

McDade was PDL's CEO from 2002 through...
To view the full article, register now.